HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.

AuthorsG Lorillon, M Robin, V Meignin, P Ribaud, B Lescoeur, D Gossot, G Socié, A Tazi, A Bergeron
JournalThe European respiratory journal (Eur Respir J) Vol. 38 Issue 2 Pg. 470-2 (Aug 2011) ISSN: 1399-3003 [Electronic] England
PMID21804164 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Bronchodilator Agents
  • Immunologic Factors
  • Immunosuppressive Agents
  • Macrolides
  • Rituximab
  • Mycophenolic Acid
  • Prednisone
  • Tacrolimus
Topics
  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Bronchiolitis Obliterans (diagnosis, drug therapy, surgery)
  • Bronchodilator Agents (therapeutic use)
  • Fatal Outcome
  • Female
  • Graft vs Host Disease (diagnosis, drug therapy)
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunologic Factors (therapeutic use)
  • Immunosuppressive Agents
  • Macrolides (therapeutic use)
  • Male
  • Mycophenolic Acid (analogs & derivatives, therapeutic use)
  • Prednisone (therapeutic use)
  • Rituximab
  • Tacrolimus (therapeutic use)
  • Transplantation Conditioning
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: